Predictors of virological failure in HIV‐1‐infected patients switching to dolutegravir maintenance monotherapy

OBJECTIVES: The Dolutegravir Monotherapy for HIV (DOMONO; NCT02401828) study showed that maintenance monotherapy with dolutegravir (DTG) is associated with virological failure (VF) and leads to DTG resistance and as a result should not be used. However, data on clinical and virological factors assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijting, IEA, Rutsaert, SL, Rokx, C, Burger, DM, Verbon, A, van Kampen, JJA, Boucher, CAB, Rijnders, BJA, Vandekerckhove, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586017/
https://www.ncbi.nlm.nih.gov/pubmed/30270543
http://dx.doi.org/10.1111/hiv.12675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586017/
https://www.ncbi.nlm.nih.gov/pubmed/30270543
http://dx.doi.org/10.1111/hiv.12675

Ejemplares similares